Approval Date: 8/31/2010
Principal Investigator: Padmaja Venuturumilli, MD
This randomized phase III trial is studying chemotherapy to see how well it works with or without bevacizumab in treating patients with recurrent or metastatic head and neck cancer.
Each study has its own guidelines for who can participate, called "eligibility criteria", with only the study doctor able to determine if you meet all eligibility criteria. More information can be found at http://clinicaltrials.gov/ct2/show/NCT00588770
CCTO Royal Oak
Status of Clinical Trial:
open and enrolling